Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
258 hedge funds and large institutions have $2.8B invested in Inari Medical, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 94 increasing their positions, 78 reducing their positions, and 37 closing their positions.
527% more call options, than puts
Call options by funds: $25M | Put options by funds: $3.99M
51% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 37
24% more capital invested
Capital invested by funds: $2.25B → $2.8B (+$548M)
21% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 78
6% more funds holding
Funds holding: 243 → 258 (+15)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$48.6M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$35M |
| 3 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$25.1M |
| 4 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$23.1M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$102M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$63.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.2M |
| 4 |
AC
Armistice Capital
New York
|
-$12.6M |
| 5 |
JP Morgan Chase
New York
|
-$11.1M |
NARI Hedge Fund Activity: Q4 2024 in Review
258 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q4 2024, worth a combined $2.8B — up 24% from $2.25B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new NARI positions and 37 closed out — a net gain of 19 holders — while 94 added to existing stakes and 78 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $48.6M. The largest seller was AllianceBernstein, cutting an estimated $102M.
- 258 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q4 2024, up from 243 in Q3 2024.
- Funds reported $2.8B of Inari Medical, Inc. Common Stock stock for Q4 2024, up 24% quarter-over-quarter.
- 56 funds opened new Inari Medical, Inc. Common Stock positions in Q4 2024 and 37 closed out, a net change of +19 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q4 2024 was Morgan Stanley, an estimated $48.6M added.
- The largest Inari Medical, Inc. Common Stock seller in Q4 2024 was AllianceBernstein, an estimated $102M sold.
Based on aggregated 13F filings for Q4 2024.